Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • ENT
    • 2018 NICE Guideline...

    2018 NICE Guideline for antibiotic prescription for Acute Sore Throat

    Written by Dr. Kamal Kant Kohli Kohli Published On 2018-01-29T19:02:20+05:30  |  Updated On 26 Aug 2023 11:44 AM IST
    2018 NICE Guideline for antibiotic prescription for Acute Sore Throat

    In order to limit the antibiotic use and reduce antimicrobial resistance, National Institute for Health and Care Excellence (NICE) has published 2018 guideline on antimicrobial prescribing strategy for an acute sore throat. An acute sore throat which is usually caused by a virus lasts for a week and patients get better without antibiotics. Most of the times non-prescription of antibiotics does not lead to complications.


    The Guidance recommends that the treating Doctors patients should note that -





    • Acute sore throat (including pharyngitis and tonsillitis) is self‑limiting and often triggered by a viral infection of the upper respiratory tract

    • symptoms can last for around 1 week, but most people will get better within this time without antibiotics, regardless of cause (bacteria or virus).




    1. Assess and manage children under 5 who present with fever as outlined in the NICE guideline on fever in under 5s. Clinicians should not use a response to antipyretic therapy alone as a means to differentiate between serious and non-serious infection

    2. Use FeverPAIN or Centor criteria to identify people who are more likely to benefit from an antibiotic.Each of the FeverPAIN criteria score 1 point (maximum score of 5). Higher scores suggest more severe symptoms and likely bacterial (streptococcal) cause. A score of 0 or 1 is thought to be associated with a 13 to 18% likelihood of isolating streptococcus. A score of 2 or 3 is thought to be associated with a 34 to 40% likelihood of isolating streptococcus. A score of 4 or 5 is thought to be associated with a 62 to 65% likelihood of isolating streptococcus.Centor criteria include
      • Tonsillar exudate
      • Tender anterior cervical lymphadenopathy or lymphadenitis
      • History of fever (over 38°C)
      • Absence of cough

    3. Give advice about:




    • the usual course of acute sore throat (can last around 1 week)

    • managing symptoms, including pain, fever and dehydration, with self-care (see the recommendations on self-care).


    4.Reassess at any time if symptoms worsen rapidly or significantly, taking account of:




    • alternative diagnoses such as scarlet fever or glandular fever

    • any symptoms or signs suggesting a more serious illness or condition

    • previous antibiotic use, which may lead to resistant organisms.


    In people who are unlikely to benefit from an antibiotic (Fever PAIN score of 0 or 1, or Centor score of 0, 1 or 2):



    1. Do not offer an antibiotic prescription.

    2. Guide them to seek medical help if symptoms worsen rapidly or significantly, do not start to improve after 1 week, or the person becomes systemically very unwell


    Recommendations about Choice of antibiotic

    When prescribing an antibiotic for acute sore throat:




    • follow table 1 for adults aged 18 years and over.

    • follow table 2 for children and young people under 18 years.




    Table 1 Antibiotics for adults aged 18 years and over































    Antibiotic 1Dosage and course length for adults 2
    First choice
    Phenoxymethylpenicillin500 mg four times a day or 1,000 mg twice a day for 5 to 10 days
    Alternative first choices for penicillin allergy or intolerance 3
    Clarithromycin250 mg to 500 mg twice a day for 5 days
    Erythromycin250 mg to 500 mg four times a day or 500 mg to 1,000 mg twice a day for 5 days
    1See BNF for appropriate use and dosing in specific populations, for example, hepatic impairment, renal impairment, pregnancy and breastfeeding.

    2Doses given are by mouth using immediate-release medicines, unless otherwise stated.

    3Erythromycin is preferred in women who are pregnant.




    Table 2 Antibiotics for children and young people under 18 years

































    Antibiotic 1Dosage and course length for children and young people 2
    First choice
    Phenoxymethylpenicillin1 to 11 months, 62.5 mg four times a day or 125 mg twice a day for 5 to 10 days

    1 to 5 years, 125 mg four times a day or 250 mg twice a day for 5 to 10 days

    6 to 11 years, 250 mg four times a day or 500 mg twice a day for 5 to 10 days

    12 to 17 years, 500 mg four times a day or 1,000 mg twice a day for 5 to 10 days
    Alternative first choices for penicillin allergy or intolerance 3
    Clarithromycin1 month to 11 years:
    Under 8 kg, 7.5 mg/kg twice a day for 5 days
    8 to 11 kg, 62.5 mg twice a day for 5 days
    12 to 19 kg, 125 mg twice a day for 5 days
    20 to 29 kg, 187.5 mg twice a day for 5 days
    30 to 40 kg, 250 mg twice a day for 5 daysor
    12 to 17 years, 250 mg to 500 mg twice a day for 5 days
    Erythromycin1 month to 1 year, 125 mg four times a day or 250 mg twice a day for 5 days

    2 to 7 years, 250 mg four times a day or 500 mg twice a day for 5 days

    8 to 17 years, 250 mg to 500 mg four times a day or 500 mg to 1,000 mg twice a day for 5 days
    1See BNF for children for appropriate use and dosing in specific populations, for example hepatic impairment and renal impairment.

    2The age bands apply to children of average size and, in practice, the prescriber will use the age bands in conjunction with other factors such as the severity of the condition and the child's size in relation to the average size of children of the same age. Doses given are by mouth using immediate‑release medicines, unless otherwise stated.

    3Erythromycin is preferred in young women who are pregnant.



    For further reference log on to :

    https://www.nice.org.uk/guidance/ng84

    For visual summary log on to :


    breastfeedingClarithromycinErythromycinNational Institute for Health and Care ExcellenceNICE guidelinesPhenoxymethylpenicillin

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Dr. Kamal Kant Kohli Kohli
    Dr. Kamal Kant Kohli Kohli
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok